Literature DB >> 7062219

Pharmacology of trimethoprim-sulfamethoxazole in newborn infants.

C Springer, F Eyal, J Michel.   

Abstract

The pharmacokinetic parameters of sulfamethoxazole and trimethoprim were measured in 12 newborn infants of less than 3 days postnatal age, following a single or repeated intravenous injection. The mean half-lives for SMZ and TMP were 16.5 hours and 19.0 hours, respectively. The mean volumes of distribution were SMZ 0.48 L/kg and TMP 2.7 L/kg. The mean drug clearances were SMZ 0.65 ml/minute and TMP 3.31 ml/minute. From these data the recommended loading dose is SMZ 10 mg/kg with TMP 3 mg/kg, and the maintenance dose is SMZ 3 mg/kg with TMP 1 mg/kg twice daily. No adverse side effects were seen during treatment, and the bilirubin-binding capacity of albumin were not changed at therapeutic concentrations of the antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062219     DOI: 10.1016/s0022-3476(82)80778-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  11 in total

1.  Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Pneumonia in a Neonate.

Authors:  Karen Leask Ryan; Deonne Dersch-Mills; Deborah Clark
Journal:  Can J Hosp Pharm       Date:  2013-11

2.  Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.

Authors:  Claire Pressiat; Veronique Mea-Assande; Caroline Yonaba; Jean-Marc Treluyer; Désiré-Lucien Dahourou; Madeleine Amorissani-Folquet; Stéphane Blanche; François Eboua; Diarra Ye; Gabrielle Lui; Karen Malateste; Yi Zheng; Valeriane Leroy; Déborah Hirt
Journal:  Br J Clin Pharmacol       Date:  2017-09-20       Impact factor: 4.335

3.  Neonatal pharmacology--a practical approach.

Authors:  D A MacKintosh
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

6.  Changes in trimethoprim pharmacokinetics after the newborn period.

Authors:  K Hoppu
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

Review 7.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

8.  Trimethoprim sulphamethoxazole in neonatal Flavobacterium meningosepticum infection.

Authors:  N Linder; S H Korman; F Eyal; J Michel
Journal:  Arch Dis Child       Date:  1984-06       Impact factor: 3.791

Review 9.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

10.  External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole.

Authors:  Yi Shuan S Wu; Michael Cohen-Wolkowiez; Christoph P Hornik; Jacqueline G Gerhart; Julie Autmizguine; Marjan Cobbaert; Daniel Gonzalez
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.